Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Long COVID resurfaces in the national dialogue after long absence from the headlines
In early 2025 public health researchers at City University of New York projected Long COVID would cost the U.S. $6.6 billion over three years. This week two members of that research team amplified their findings and updated their projections.
5 points of light in the darkness of ‘healthcare’s moral emergency’
Western medicine often functions more like a high-tech patient-processing machine than a high-touch people-healing mission. This can and must change, argue three distinguished healthcare thought leaders.
America is clearly losing the war on drugs in some states, arguably winning in others
The state with the worst illicit drug problem is also home to the largest percentage of teenage users.
ROI research: Community health workers are an unsung bargain
U.S. healthcare gets plenty of bang for its buck out of community health workers (CHWs), according to a systematic review of the relevant published research.
Despite 63% increase in mental health utilization, overdoses and suicides for men rise
No group fared particularly well in an analysis from Trilliant Health looking at publicly reported data. Most of the new utilization of mental health services was for anxiety, with women seeking care most often.

AI-powered EHR alerts make a world of difference for cardiologists, heart patients

AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.

Michiel Voskuil, MD, PhD, an interventional cardiologist and professor at University Medical Center Utrecht in the Netherlands, presented his team’s data on the ACC.26 stage.

PCI before TAVR? In older CAD patients, deferral may be the best approach

Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.

XCath Robotics, a Houston-based medical robotics company, announced the successful completion of the world’s first telerobotic stroke operation of its kind. Neurosurgeon Vitor Mendes Pereira, MD, chair of advanced neurovascular interventions at the University of Toronto, used the XCath Iris Surgical Robotic System to perform the historic procedure.

World’s first telerobotic neurosurgery performed on stroke patient 120 miles away

Neurosurgeon Vitor Mendes Pereira, MD, was in Santiago, Panama, but his patient was in Panama City. "It is the highlight of my career to be involved in this historic achievement," Pereira said.

intrasaccular flow disruptor coronary aneurysm

Cardiologists use endovascular device for brain aneurysms to treat high-risk heart patients

A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.

When heart patients can’t wait: Urgent TAVR with self-expanding vs. balloon-expandable valves

The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities.

More than 80% of clinicians have had to correct AI-supplied misinformation during patient visits: New patient + provider survey

Meanwhile members of Gen Z are twice as likely as other generations to get sneaky about their use of medical AI.

6 things Medicaid stakeholders can remind the world to always do with healthcare AI

U.S. healthcare will know it’s gotten AI right when the technology demonstrably improves care access, attentiveness and outcomes for the least financially healthy among us.

Vascudyne's off-the-shelf conduit for CABG surgeries

New off-the-shelf conduit for CABG shows promise in first-in-human study

A new acellular tissue-engineered vessel developed by Vascudyne could provide surgeons with a safe, effective alternative to saphenous vein grafts.

Care Delivery

Long COVID resurfaces in the national dialogue after long absence from the headlines

5 points of light in the darkness of ‘healthcare’s moral emergency’

America is clearly losing the war on drugs in some states, arguably winning in others

ROI research: Community health workers are an unsung bargain

Despite 63% increase in mental health utilization, overdoses and suicides for men rise